FDA Approves 1st Biosimilar Drug

March 9, 2015 11:20 AM

17 0

On Friday, the Food and Drug Administration approved what's called a biosimilar version of the cancer drug Neupogen. This is a big step forward in lowering the cost of the most expensive drugs.

A recent study estimates biosimilar drugs could save Americans $44 billion dollars over the next ten years.

Read more

To category page